journal article·2026-06Open access

Injectable Porous Microspheres Loaded With Biomimetic Preconditioned Bone Marrow Mesenchymal Stem Cell‐Derived Exosomes for Vascularized Bone Regeneration

Lijun Li, Hao Zhang, Lingtong Sun, Yingfeng Su, Yang Xu, Jian Huang, Jingchao Wen, Jinjin Zhu, Jianjun Ma, Wenbin Xu

Advanced Science· Volume 13· Issue 32

Abstract

ABSTRACT Critical‐sized bone defects remain a highly challenging clinical problem due to insufficient intrinsic self‐healing capacity. Bone marrow mesenchymal stem cell (BMSC)‐derived exosomes have emerged as promising cell‐free therapeutic candidates for bone regeneration, owing to their paracrine effects in regulating bone regeneration‐related processes. However, enhancing exosome bioactivity via biomimetic preconditioning and developing efficient delivery vectors remain key bottlenecks in this field. Herein, we developed a synergistic bone regenerative system composed of biomimetic preconditioned BMSC‐derived exosomes (BioPre‐Exos) and injectable porous polydopamine (PDA)‐modified gelatin methacryloyl (GelMA) microspheres. The biomimetic preconditioning strategy adopted 3% hypoxia combined with 3D GelMA microsphere culture, mimicking the bone marrow microenvironment to regulate BMSC functions and significantly boost exosome bioactivity. Functional experiments verified that BioPre‐Exos robustly promoted BMSC migration, osteogenic differentiation, angiogenesis, and macrophage polarization toward an anti‐inflammatory phenotype in vitro. Furthermore, in a rat femoral condyle defect model, the composite system markedly improved neovascularization density and bone volume fraction, thus achieving efficient vascularized bone regeneration. These findings indicate that this cell‐free biomimetic synergistic delivery system holds great application potential in the clinical treatment of bone defects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Bone Tissue Engineering Materials · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery Sir Run Run Shaw Hospital Zhejiang University School of Medicine & Zhejiang Key Laboratory of Mechanism Research and Precision Repair of Orthopaedic Trauma and Aging Diseases Hangzhou Zhejiang China

College of Pharmaceutical Sciences Zhejiang Chinese Medical University Hangzhou China

Hangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University Hangzhou Zhejiang China

Department of Thoracic Surgery Zhejiang Cancer Hospital Hangzhou Zhejiang China

Department of Ultrasound Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China

Department of Orthopaedic Surgery the Fourth Affiliated Hospital of School of Medicine International Institutes of Medicine, and International School of Medicine International Institutes of Medicine Zhejiang University Yiwu China

Funding

National Natural Science Foundation of China

References (46)

Show source-provided references
1. 10.1038/s41586‐024‐08208‐z10.1038/s41586‐024‐08208‐z ↗
2. 10.1038/s41563‐020‐0786‐510.1038/s41563‐020‐0786‐5 ↗
3. 10.1038/s41467‐025‐57609‐910.1038/s41467‐025‐57609‐9 ↗
4. 10.1002/adma.20251446110.1002/adma.202514461 ↗
5. 10.1126/sciadv.adi679910.1126/sciadv.adi6799 ↗
6. 10.1002/adma.20240773010.1002/adma.202407730 ↗
7. 10.1126/sciadv.adk672210.1126/sciadv.adk6722 ↗
8. 10.1002/advs.20230949110.1002/advs.202309491 ↗
9. 10.1186/s12951‐025‐03961‐310.1186/s12951‐025‐03961‐3 ↗
10. 10.1016/j.compositesb.2022.11031510.1016/j.compositesb.2022.110315 ↗
11. 10.1186/s12951‐024‐02669‐010.1186/s12951‐024‐02669‐0 ↗
12. 10.1186/s12951‐022‐01646‐910.1186/s12951‐022‐01646‐9 ↗
13. 10.1016/j.cej.2024.15137210.1016/j.cej.2024.151372 ↗
14. 10.1016/j.mtbio.2025.10187410.1016/j.mtbio.2025.101874 ↗
15. 10.1016/j.bioactmat.2025.08.02610.1016/j.bioactmat.2025.08.026 ↗
16. 10.1016/j.cej.2020.12804010.1016/j.cej.2020.128040 ↗
17. 10.1631/bdm.240023110.1631/bdm.2400231 ↗
18. 10.1021/acsnano.5c0325610.1021/acsnano.5c03256 ↗
19. 10.1016/j.cej.2024.14968110.1016/j.cej.2024.149681 ↗
20. 10.1016/j.cej.2025.17141010.1016/j.cej.2025.171410 ↗
21. 10.1016/j.actbio.2022.11.06510.1016/j.actbio.2022.11.065 ↗
22. 10.1002/adma.20221160210.1002/adma.202211602 ↗
23. 10.1186/s12951‐024‐02538‐w10.1186/s12951‐024‐02538‐w ↗
24. 10.1182/blood‐2019‐12864210.1182/blood‐2019‐128642 ↗
25. 10.1016/j.actbio.2022.02.02610.1016/j.actbio.2022.02.026 ↗
26. 10.1002/EXP.2021003610.1002/EXP.20210036 ↗
27. 10.1021/acsbiomaterials.8b0090810.1021/acsbiomaterials.8b00908 ↗
28. 10.1021/acsbiomaterials.9b0138110.1021/acsbiomaterials.9b01381 ↗
29. 10.1002/smll.20220462510.1002/smll.202204625 ↗
30. 10.1016/j.cej.2025.16622110.1016/j.cej.2025.166221 ↗
31. 10.1016/j.actbio.2019.12.02010.1016/j.actbio.2019.12.020 ↗
32. 10.1186/s12951‐023‐02098‐510.1186/s12951‐023‐02098‐5 ↗
33. 10.1016/j.biomaterials.2019.11955210.1016/j.biomaterials.2019.119552 ↗
34. 10.1016/j.carbpol.2024.12284710.1016/j.carbpol.2024.122847 ↗
35. 10.1016/j.bioactmat.2025.04.01910.1016/j.bioactmat.2025.04.019 ↗
36. 10.1186/s12951‐025‐03222‐310.1186/s12951‐025‐03222‐3 ↗
37. 10.1126/sciadv.adq670010.1126/sciadv.adq6700 ↗
38. 10.1002/adfm.20230820510.1002/adfm.202308205 ↗
39. 10.7150/thno.5074110.7150/thno.50741 ↗
40. 10.1021/acsnano.4c1196010.1021/acsnano.4c11960 ↗
41. 10.1016/j.bioactmat.2025.07.03810.1016/j.bioactmat.2025.07.038 ↗
42. 10.1002/advs.20240804410.1002/advs.202408044 ↗
43. 10.1002/adfm.20242199310.1002/adfm.202421993 ↗
44. 10.1016/j.jconrel.2021.03.03110.1016/j.jconrel.2021.03.031 ↗
45. 10.1002/smll.20240368110.1002/smll.202403681 ↗
46. 10.1016/j.compositesb.2022.11009910.1016/j.compositesb.2022.110099 ↗